This is an open-label, multi-centre, multi-national, single-period, randomised, parallel group design study, involving a 12 month period of home study during which day and night glucose levels will be controlled either by a closed-loop system combined with low glucose feature (intervention group) or by insulin pump therapy alone (control group).